AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational ...

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

The Emblem MRI S-ICD, Boston Scientific's latest-generation S-ICD system, is being evaluated in the company's recently-initiated MADIT S-ICD study. It's one thing when a device performs well during a ...

For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Patients with an indication for an implantable cardiac defibrillator for primary prevention of sudden cardiac death and a sharply reduced left ventricular ejection fraction of 35% or less safely ...

Traditionally implantable cardioverter defibrillators (ICDs) have been implanted transvenously by creating a pouch in the subclavicular area and gaining vascular access to the heart. This approach, ...

A cohort study of more than 600 persons with non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) found that these ICDs still appropriately treated detected ...

In a recent column, we discussed pacemakers. In this one, we’ll continue on the general topic of heart regulation with information about implantable cardioverter-defibrillators. An implantable ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Subcutaneous implantable cardioverter ...

Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices. Among patients hospitalized with ...